Search Results 91-100 of 16510 for HMB loading phase

1. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... load within 6 months of screening and enrollment are eligible for this trial.

2. Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   The primary objectives of this study are to evaluate the effect of Elafibranor treatment compared to placebo on 1) histological improvement and 2) all-cause ...

3. Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. - Mayo Clinic

   In the later phase (phase 3), researchers study whether the treatment works ... There are also less common very early (phase 0) and later (phase 4) phases.

5. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   PURPOSE: This randomized phase II trial is studying giving bendamustine hydrochloride and rituximab together with or without bortezomib followed by rituximab ...

6. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

   Therefore, these robust preclinical findings will be tested in the proposed phase I trial. Participation eligibility. Participant eligibility includes age, ...

7. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... undetectable HBV viral load on suppressive therapy within 28 days prior to

8. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Giving veliparib with chemotherapy may kill more tumor cells. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...

9. A Study Of VR To Improve Tolerability During Paracentesis And Liver Biopsies - Mayo Clinic

   Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and ...

10. Safety And Efficacy Of A Lysophosphatidic Acid Receptor Antagonist In Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...